Drugs

A federal bankruptcy judge has signed off on OxyContin maker Purdue Pharma's plan to settle billions in lawsuits over the opioid crisis.

Despite more than seven months in office, President Biden has still not gotten a permanent head of the Food and Drug Administration installed.

A member of the Sackler family that owns OxyContin maker Purdue Pharma says the billionaires will not agree to a settlement unless it includes liability protections for the heirs against waves of lawsuits over the opioid crisis.

A Japanese company has started human trials of the first once-a-day pill for Covid-19 patients, joining Pfizer Inc. and Merck & Co. in the race to find treatments for the disease.

The parents of a 16-year-old boy who died from a fentanyl overdose have started a petition calling on social media apps like TikTok and Snapchat to change their policies.

The Belmont Stakes, one of the country’s oldest horse racing events, usually draws a crowd in excess of 100,000, has an economic impact on Long Island of more than $10 million and is the last jewel in the quest for thoroughbred racing’s Triple Crown. The 2021 edition will have none of those on Saturday.

A recent lawsuit over THC-laced edibles and packaging raises the question whether cannabis companies are aiming to draw in adolescents as a possible market.

An organization working to lower prescription drug prices is launching a seven-figure ad blitz that spotlights patients calling on members of Congress "to keep their promises" by supporting a drug pricing reform bill that would give Medicare the power to negotiate "lower prices for all Americans."

A possible new coronavirus vaccine candidate produced by Sanofi and GSK (GlaxoSmithKline) that uses the human body’s own antigens to neutralize antibody responses for people who have already recovered from the illness, has completed Phase 2 trials, the companies said Monday.